
Telomir Pharmaceuticals Inc. (NASDAQ:TELO) jumped 38.71% during after-hours trading on Monday, climbing to $1.97 after the company released promising preclinical study results for its lead compound, Telomir-1.
Check out the current price of TELO stock here.